From Name:
From Email:
To Name:
To Email:

Optional Message:


Olaratumab approved for soft tissue sarcoma

from ASHP

The FDA recently approved olaratumab as part of a treatment regimen for soft tissue sarcoma in adults. Olaratumab, according to its labeling, is indicated, in conjunction with doxorubicin therapy, for patients whose soft tissue sarcoma is suitable for treatment with an anthracycline regimen and for whom radiotherapy or surgery are not options. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063